• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    India Rapid Diagnostics Market

    ID: MRFR/MED/43670-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    India Rapid Diagnostics Market Research Report By Application (Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing) and By Product Type (Over the Counter (OTC) Kits, Professional Kits)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    India Rapid Diagnostics Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    India Rapid Diagnostics Market Summary

    The India Rapid Diagnostics market is projected to grow from 2500 USD Million in 2024 to 5000 USD Million by 2035.

    Key Market Trends & Highlights

    India Rapid Diagnostics Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate of 6.5 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 5000 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 2500 USD Million, reflecting a strong foundation for future expansion.
    • Growing adoption of rapid testing technologies due to increasing healthcare accessibility is a major market driver.

    Market Size & Forecast

    2024 Market Size 2500 (USD Million)
    2035 Market Size 5000 (USD Million)
    CAGR (2025 - 2035) 6.5%

    Major Players

    Reliance Industries Limited (IN), Tata Consultancy Services (IN), HDFC Bank Limited (IN), Infosys Limited (IN), ICICI Bank Limited (IN), Hindustan Unilever Limited (IN), State Bank of India (IN), Bharti Airtel Limited (IN), Wipro Limited (IN), Asian Paints Limited (IN)

    India Rapid Diagnostics Market Trends

    The India Rapid Diagnostics Market is significantly expanding on account of the growing requirement for point-of-care testing services across several healthcare facilities. There is also a growing adoption of rapid diagnostic tests across hospitals, clinics, and patients’ homes due to the increasing prevalence of infectious diseases along with the need for effective and efficient diagnostics. In addition, the development and funding of basic healthcare services and facilities by the government is an important driver of the market.

    The National Health Mission and other government efforts for better control and prevention of diseases are promoting the use of rapid diagnostic tools for public health issues in India.

    The Indian market presents a lot of opportunities because the case of increased technological innovation and better awareness among the healthcare professionals and general public inspires new diagnostic products. Increased health awareness after the pandemic has led to the adoption and reliance on rapid diagnostics and innovative solutions. This aids local manufacturers and startups ready to meet the needs of the people, even those in rural areas where orthodox hospitals and laboratories face a lot of challenges.

    These days, there is a clear movement toward telehealth services that combine rapid diagnostic tests with virtual consultations, where patients can quickly have their test results and medical attention facilitated.

    Moreover, the recent tendency towards the integration of the services provided by the public and private sectors enables better and faster diagnosis to be done all over the country. As the enacting of the laws relating diagnostic tools changes, there is likely to be an increasing scope of for collaboration and investments which will further propel the rapid diagnostics industry in India.

    Market Segment Insights

    India Rapid Diagnostics Market Segment Insights

    India Rapid Diagnostics Market Segment Insights

    Rapid Diagnostics Market Application Insights

    Rapid Diagnostics Market Application Insights

    The India Rapid Diagnostics Market is rapidly evolving, particularly within the Application segment, which plays a pivotal role in ensuring accessible healthcare solutions across the nation. This segment encompasses a variety of crucial analytical methods, including Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, and Toxicology Testing. 

    Each of these applications serves distinct yet significant needs in the healthcare landscape. Blood Glucose Testing has become essential for the management of diabetes, catering to a growing diabetic population in India. With an increasing number of people being diagnosed with this chronic illness, the demand for accurate and quick monitoring solutions continues to rise, promoting better health management practices.Infectious Disease Testing is also gaining traction, especially in the context of public health initiatives aimed at combating prevalent diseases such as tuberculosis, malaria, and HIV. 

    The ability to swiftly identify infections supports timely intervention and treatment, crucial for containing outbreaks and improving overall community health metrics. Similarly, Cardiometabolic Testing plays a vital role in assessing cardiovascular and metabolic health, which is critical in a country experiencing a rise in lifestyle-related diseases due to urbanization and changing diets.Pregnancy Fertility Testing remains a focal application, with many couples seeking timely answers for family planning and reproductive health. 

    This application not only highlights the importance of early detection but also significant advancements in testing technologies that facilitate patient convenience. On the other hand, Fecal Occult Blood Testing provides screenings for colorectal cancer, an essential part of preventive healthcare strategies, especially given India's growing emphasis on early cancer detection.Coagulation Testing, crucial for diagnosing bleeding disorders and monitoring patients on anticoagulants, addresses an integral healthcare aspect, ensuring safe treatment protocols for individuals with specific medical needs.

    Rapid Diagnostics Market Product Type Insights

    Rapid Diagnostics Market Product Type Insights

    The India Rapid Diagnostics Market is characterized by a diverse range of product types, with Over the Counter (OTC) Kits and Professional Kits emerging as key segments. OTC Kits, commonly accessible to consumers without the need for a prescription, enable rapid testing for various conditions, enhancing self-diagnosis and health management. This segment has seen notable demand due to the increasing awareness of health issues and the emphasis on preventative care among the Indian population.

    Meanwhile, Professional Kits cater to healthcare providers, offering reliable solutions for accurate diagnosis in clinical settings.These kits play a critical role in streamlining patient management and improving healthcare outcomes. The growth of both segments is fueled by rising healthcare expenditure, increased prevalence of infectious diseases, and advancements in technology, alongside the growing trend of digital health solutions in India.

    The adaptability and convenience of OTC Kits combined with the trusted efficacy of Professional Kits position both segments favorably within the market, reflecting robust potential in enhancing diagnostic accessibility across various demographics in the country.The expanding healthcare infrastructure and supportive government initiatives further bolster the prospects for growth in the India Rapid Diagnostics Market.

    Get more detailed insights about India Rapid Diagnostics Market Research Report- Forecast to 2035

    Key Players and Competitive Insights

    The India Rapid Diagnostics Market is witnessing significant growth, driven by an increased prevalence of infectious diseases and a rising demand for quick and accurate diagnostic solutions. The competitive landscape in this market is characterized by both global players and regional companies that are striving to innovate and offer a diverse range of products. The market is influenced by various factors including technological advancements, changing healthcare policies, and an expanding healthcare infrastructure that emphasizes the importance of rapid testing.

    As the healthcare sector continues to evolve, companies are focusing on strategic partnerships, collaborations, and advancements in diagnostics technology to enhance their market presence and meet the growing needs of healthcare providers and patients.Medtronic has established a notable presence in the India Rapid Diagnostics Market by capitalizing on its strengths in medical technology and innovation. The company’s commitment to providing high-quality diagnostics solutions has enabled it to cater effectively to the evolving healthcare demands in India. 

    Medtronic's strong focus on research and development has led to the introduction of state-of-the-art products tailored for the Indian population, addressing specific health challenges. Moreover, its efficient distribution network enhances its ability to deliver timely diagnostic solutions across various regions of India, thereby solidifying its position as a key player in the market. The company also engages in educational initiatives and training for healthcare professionals, further strengthening its reputation and influence in the rapid diagnostics space.Abbott plays a crucial role in the India Rapid Diagnostics Market, known for its broad portfolio of innovative diagnostic products and services. 

    The company's key offerings include rapid tests for infectious diseases, molecular diagnostics, and point-of-care testing solutions, which cater to the diverse needs of Indian healthcare providers. Abbott's robust market presence is underpinned by a strong distribution network that ensures accessibility to its products across urban and rural areas. The company has consistently focused on strategic partnerships and collaborations with local healthcare institutions, allowing them to enhance their market reach. 

    Furthermore, Abbott has made notable investments in research and development specific to the Indian market, enabling them to introduce products that align with local health conditions. With a commitment to excellence and quality, Abbott continues to strengthen its position within the India Rapid Diagnostics Market.

    Key Companies in the India Rapid Diagnostics Market market include

    Industry Developments

    The India Rapid Diagnostics Market is witnessing significant developments, particularly in the context of emerging health technologies and increasing demand due to the ongoing focus on healthcare. In October 2023, Medtronic announced a new product launch aimed at enhancing rapid diagnostic capabilities, indicating a growth trajectory in this sector. Abbott's advancements in molecular diagnostics have been pivotal, particularly with their rapid testing solutions garnering attention for infectious diseases. In recent times, Dr. Lal PathLabs and Mylab Discovery Solutions have also expanded their portfolios to include innovative rapid testing methodologies. 

    Notably, Siemens Healthineers and Thermo Fisher Scientific are continuously investing in RD to bolster their market presence. Noteworthy mergers include Alere's acquisition by Abbott, which has strengthened Abbott's position in the rapid diagnostics arena. The overall market is projected to grow significantly, driven by increased government initiatives and funding in the healthcare sector, particularly following the pandemic. 

    In the last two years, the demand for rapid testing solutions has surged, underscoring the importance of timely diagnostics in India's healthcare landscape. This evolution, backed by various stakeholders, is essential for addressing public health challenges effectively.

    Market Segmentation

    Rapid Diagnostics Market Application Outlook

    • Over the Counter (OTC) Kits
    • Professional Kits

    Rapid Diagnostics Market Product Type Outlook

    • Over the Counter (OTC) Kits
    • Professional Kits

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 1.73(USD Billion)
    MARKET SIZE 2024 2.51(USD Billion)
    MARKET SIZE 2035 5.96(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.174% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Medtronic, Abbott, Dr. Lal PathLabs, Mylab Discovery Solutions, Hewlett Packard Enterprise, Arkray, ZyBio, Alere, Thermo Fisher Scientific, Roche, Siemens Healthineers, Srinivasa Diagnostics, BioRad Laboratories, Panbio, BD
    SEGMENTS COVERED Application, Product Type
    KEY MARKET OPPORTUNITIES Increased prevalence of infectious diseases, Growing demand for point-of-care testing, Rising focus on preventive healthcare, Technological advancements in diagnostics, Expansion of telemedicine services
    KEY MARKET DYNAMICS Increasing prevalence of diseases, Growing demand for rapid testing, Advancements in diagnostic technology, Rising healthcare expenditure, Expansion of healthcare infrastructure
    COUNTRIES COVERED India

    FAQs

    What is the expected market size of the India Rapid Diagnostics Market in 2024?

    The India Rapid Diagnostics Market is expected to be valued at 2.51 billion USD in 2024.

    What is the anticipated market size for the India Rapid Diagnostics Market by 2035?

    By 2035, the market is expected to grow to 5.96 billion USD.

    What is the expected CAGR for the India Rapid Diagnostics Market from 2025 to 2035?

    The anticipated compound annual growth rate (CAGR) is 8.174 percent for the period from 2025 to 2035.

    Which application segment is expected to dominate the India Rapid Diagnostics Market in 2024?

    The Blood Glucose Testing segment is expected to dominate the market, valued at 0.644 billion USD in 2024.

    What will be the market value of the Infectious Disease Testing segment by 2035?

    The Infectious Disease Testing segment is projected to reach approximately 1.344 billion USD by 2035.

    Which key players are prominent in the India Rapid Diagnostics Market?

    Major players include Medtronic, Abbott, Dr. Lal PathLabs, Mylab Discovery Solutions, and Roche among others.

    What is the market value for the Cardiometabolic Testing application in 2024?

    The Cardiometabolic Testing application is valued at 0.465 billion USD in 2024.

    How much is the Pregnancy & Fertility Testing segment expected to be valued by 2035?

    The Pregnancy & Fertility Testing segment is expected to reach 0.865 billion USD by 2035.

    What is the projected market value for Fecal Occult Blood Testing in 2024?

    Fecal Occult Blood Testing is projected to have a market value of 0.4 billion USD in 2024.

    What growth drivers are influencing the India Rapid Diagnostics Market?

    Key growth drivers include increasing health awareness, technological advancements, and a rise in infectious diseases.

    India Rapid Diagnostics Market Research Report- Forecast to 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials